A second merozoite surface protein (MSP-4) of Plasmodium falciparum that contains an epidermal growth factor-like domain

Infection and Immunity

Volumn 65, Issue 11, 1997, Pages 4460-4467

  Marshall, Vikki M ^a,c   Silva, Anabel ^a   Foley, Michael ^a,d   Cranmer, Sue ^b,e   Wang, Lina ^b   McColl, Damian J ^a,f   Kemp, David J ^a,g   Coppel, Ross L ^b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d LA TROBE UNIVERSITY   (Australia)

^e BOX HILL HOSPITAL   (Australia)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DETERGENT; EPIDERMAL GROWTH FACTOR; GLYCOSYLPHOSPHATIDYLINOSITOL; MEMBRANE PROTEIN; MESSENGER RNA; MYRISTIC ACID; NUCLEOTIDE;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; GENE; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MALARIA; MEROZOITE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS;

EID: 0030832976     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.11.4460-4467.1997     Document Type: Article

References (48)

1. Bell, G. I., N. M. Fong, M. M. Stempien, M. Wormsted, D. Caput, L. Ka. M. S. Urdea, L. B. Rall, and R. Sanchez-Pescador. 1986. Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization. Nucleic Acids Res. 14:8427-8446.
2. Bianco, A. E., P. E. Crewther, R. L. Coppel, H. D. Stahl. D. J. Kemp, R. F. Anders, and G. V. Brown. 1988. Patterns of antigen expression in asexual blood stages and gametocytes of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 38:258-267.
3. Blackman, M. J., H. G. Heidrich, S. Donachie, J. S. McBride, and A. A. Holder. 1990. A single fragment of malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J. Exp. Med. 172:379-382.
4. Blackman, M. J., H. Whittle, and A. A. Holder. 1991. Processing of the Plasmodium falciparum major merozoite surface protein-1: identification of a 33-kilodalton secondary processing product which is shed prior to erythrocyte invasion. Mol. Biochem. Parasitol. 49:35-44.
5. Bottius, E., L. Benmohamed, K. Brahimi, H. Gras. J. P. Lepers, L. Rahari-malala, M. Aikawa, J. Meis, B. Slierendregt, A. Tartar, A. Thomas, and P. Druilhe. 1996. A novel Plasmodium falciparum sporozoite and liver stage antigen (Salsa) defines major B. T helper, and Ctl epitopes. J. Immunol, 156:2874-2884.
6. Campbell, I. D., and P. Bork. 1993. Epidermal growth factor-like modules. Curr. Opin. Struct. Biol. 3:385-392.
7. Chang, S. P., H. L. Gibson, C. T. Lee-Ng, P. J. Barr, and G. S. N. Hui. 1992. A carhoxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. J. Immunol. 149:548-555.
8. Chappel, J. A., and A. A. Holder. 1993. Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1. Mol. Biochem. Parasitol. 60:303-312.
9. Cooke, R. M., A. J. Wilkinson, M. Baron, A. Pastore, M. J. Tappin, I. D. Campbell, H. Gregory, and B. Sheared. 1987. The solution structure of human epidermal growth factor. Nature 327:339-341.
10. Cooper, J. A. 1993. Merozoite surface antigen-1 of Plasmodium. Parasitol. Today 9:50-54.
11. Cooper, J. A., L. T. Cooper, and A. J. Saul. 1992. Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA 1. Mol. Biochem. Parasitol. 51:301-312.
12. Coppel, R. L. 1992. Malaria-revealing the ties that bind. Parasitol. Today 8:393-394.
13. Coppel, R. L. 1995. The contribution of molecular biology to our understanding of malaria. Bailliere's Clin. Infect. Dis. 2:351-369.
14. Crewther, P. E., A. E. Bianco, G. V. Brown, R. L. Coppel, H. D. Stahl, D. J. Kemp. and R. F. Anders. 1986 Affinity purification of human antibodies directed against cloned antigens of Plasmodium falciparum. J. Immunol. Methods 86:257-264.
15. Crewther, P. E., J. G. Culvenor, A. Silva, J. A. Cooper, and R. F. Anders. 1990. Plasmodium falciparum: two antigens of similar size are located in different compartments of the rhoptry. Exp. Parasitol. 70:193-206.
16. Culvenor, J. 1995. Personal communication.
17. Daly, T. M., and C. A. Long. 1993. A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium 17XL merozoite surface protein 1 induces a protective immune response in mice. Infect. Immun. 61: 2462-2467
18. Dame, J. B.. J. L. Williams. T. F. McCutchan. J. L. Weber. R. A. Wirtz, W. T. Hockmeyer. W. L. Maloy. 1. Schneider. D. Roberts. G. S. Sanders. E. P. Reddy. C. L. Diggs. and L. H. Miller. 1984. Structure of the gene encoding the immunodominant surface antigen on the sporozoitc of the human malaria parasite Plasmodium falciparium. Science 225:593-599.
19. Davis. C. G. 1990. The many faces of epidermal growth factor repeats. New Biol. 2:410-419.
20. Duffy. P. E., P. Pimenta, and D. C. Kaslow. 1993. Pgs28 belongs to a family of epidermal growth factor-like antigens that are targets of malaria transmission-blocking antibodies. J. Exp. Med. 177:505-510.
21. Engelmann, B., U. Schumacher, and E. Haen. 1992. Epidermal growth factor binding sites on human crythricytes in donors with different ABO blood groups. Am. J. Haematol. 39:239-241.
22. Fenton, B., J. T. Clark, C. F. Wilson, J. S. McBride. and D. Walliker. 1989. Polymorphism of a 35-48 kDa Plasmodium falciparum merozoite surface antigen. Mol. Biochem. Parasitol. 34:79-86.
23. Haldar, K., M. A. Ferguson, and G. A. Cross. 1985. Acylation of a Plasmodium falciparum merozoite surface antigen via sn-1.2-diacyl glycerol. J. Biol. Chem. 260:4969-4974.
24. Holder, A. A., M. J. Blackman, M. Borre. P. A. Burghaus, J. A. Chappel. J. K. Keen, I. T. Ling, S. A. Ogun, C. A. Owen, and K. A. Sinha. 1994. Malaria parasites and erythrocyte invasion. Biochem. Soc. Trans. 22:291-295.
25. Holder, A. A., and R. R. Freeman. 1984. The three major antigens on the surface of Plasmodium falciparum merozoites are derived from a single high molecular weight precursor. J. Exp. Med. 160:624-629.
26. Holder, A. A., M. J. Lockyer, K. G. Odink, J. S. Sandhu, M. V. Riveros, L. S. Davey, M. L. V. Tizard, R. T. Schwarz, and R. R. Freeman. 1985. Primary structure of the precursor to the three major surface antigens of Plaamodium falciparum merozoites. Nature 317:270-273.
27. Kaslow, D. C., S. N. Isaacs, I. A. Quakyi, R. W. Gwadz, B. Moss, and D. B. Keister. 1991. Induction of Plasmodium fulciparum transmission-blocking antibodies by recombinant vaccinia virus. Science 252:1310-1313.
28. Kaslow, D. C., I. A. Quakyi, C. Syin, M. G. Raum, D. B. Keister, J. E. Coligan, T. F. McCulchan. and L. H. Miller. 1988 A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains. Nature 333:74-76.
29. Lambros, C., and J. P. Vanderberg. 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:418-420.
30. Lanzer, M., S. P. Wertheimer, D. De Bruin, and J. V. Ravetch. 1993. Plas-modium: control of gene expression in malaria parasites. Exp. Parasitol, 77:121-128.
31. Levitt, A., F. O. Dimayuga, and V. R. Ruvolo. 1993. Analysis of malarial transcripts using cDNA-direeted polymerase chain reaction. J Parasitol. 79:653-663.
32. Ling, I. T., S. A. Ogun, and A. A. Holder. 1994. Immunization against malaria with a recombinant protein. Parasite Immunol. 16:63-67.
33. Marshall, V. M., L. X. Zhang, R. F. Anders, and R. L. Coppel. 1996. Diversity of the vaccine candidate AMA-1 of Plasmodium falciparum. Mol. Biochem. Parasitol. 77:109-113.
34. McBride, J. S., and H. G. Heidrich. 1987. Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex. Mol. Biochem. Parasitol. 23:71-84.
35. McColl, D. J., A. Silva, M. Foley, J. F. J. Kun, J. M. Favaloro, J. K. Thompson, V. M. Marshall, R. L. Coppel, D. J. Kemp, and R. F. Anders. 1994. Molecular variation in a novel polymorphic antigen associated with Plasmodium falciparum merozoites. Mol. Biochem. Parasitol. 68:53-67.
36. Mitchell, G. H., and L. H. Bannister. 1988. Malaria parasite invasion: interactions with the red cell membrane. Crit. Rev. Oncol Hematol. 8:225-310.
37. Oduola, A. M., W. K. Milhous, N. F. Weatherly, J. H. Bowdre, and R. E. Desjardins. 1988. Plasmodium falciparum: induction of resistance to mefloquine in cloned strains by continuous drug exposure in vitro. Exp. Parasitol. 67:354-360.
38. Oeuvray, C., H. Bouharoun-Tayoun, H. Grass-Masse, J. Lepers, L. Ralam-boranto, A. Tartar, and P. Druilhe. 1994. A novel merozoite surface antigen of Plasmodium falciparum (MSP-3) identified by cellular-antibody cooperative mechanism antigenicity and biological activity of antibodies. Mem. Inst. Oswaldo Cruz 89(Suppl. II):77-80.
39. Oeuvray, C., H. Bouharountayoun, H. Grasmasse, E. Bottius, T. Kaidoh, M. Aikawa, M. C. Filgueira, A. Tartar, and P. Druilhe. 1994. Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes. Blood 84:1594-1602.
40. Rosenthal, P. J. 1995. Plasmodium falciparum-effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites. Exp. Parasitol. 80: 272-281.
41. Saul, A., R. Lord, G. Jones, H. M. Geysen, J. Gale, and R. Mollard. 1989 Cross-reactivity of antibody against an epitope of the Plasmodium fulciparum second merozoite surface antigen. Parasite Immunol. 11:593-601.
42. Sinnis, P., and B. K. L. Sim. 1997. Cell invasion by vertebrate stages of Plasmodium. Trends Microbiol. 5:52-58.
43. Smith, D. B., and K. S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31 -40.
44. Smythe, J. A., R. L. Coppel, G. V. Brown, K. Ramasamy, D. J. Kemp, and R. F. Anders. 1988. Identification of two integral membrane proteins of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 85:5195-5199.
45. Smythe, J. A., R. L. Coppel, K. P. Day, R. K. Martin, A. M. J. Oduola, D. J. Kemp, and R. F. Anders. 1991. Structural diversity in the Plasmodium falci- parum merozoite surface antigen MSA-2. Proc. Natl. Acad. Sci. USA 88: 1751-1755.
46. Smythe, J. A., P. J. Murray, and R. F. Anders. 1990. Improved temperature-dependent phase separation using Triton X-114: isolation of integral membrane proteins of pathogenic parasites. J. Methods Cell Mol. Biol. 2:133-137.
47. Thomas, A. W., A. P. Waters, and D. Carr. 1990. Analysis of variation in Pf83. an erythrocyte merozoite vaccine candidate antigen of Plasmodium falciparum. Mol. Biochem. Parasitol. 42:285-288.
48. Trottein, F., and A. F. Cowman. 1995. Molecular cloning and sequence of two novel P-type adenosinetriphosphatases from Plasmodium falciparum. Eur. J. Biochem. 227:214-225.